The next symposia will take place from the 3rd to the 7th of September 2018 at the conference center Rheingoldhalle in Mainz, Germany.
Read more: Joint European Magnetic Symposia (JEMS), 03-07 Sep 2018, Mainz (Germany)
J. Muñoz, A. González-Campo, M. Riba-Moliner, M. Baeza and M. Mas-Torrent
Francesc Bejarano, Ignacio Jose Olavarria-Contreras, Andrea Droghetti, Ivan Rungger, Alexander Rudnev, Diego Gutiérrez, Marta Mas-Torrent, Jaume Veciana, Herre S. J. van der Zant, Concepció Rovira, Enrique Burzurí and Núria Crivillers
Read more: Pressure-Responsive, Surfactant-Free CO2-Based Nanostructured Fluids
Dorothy A. Silbaugh, Lidia Ferrer-Tasies, Jordi Faraudo, Jaume Veciana, Nora Ventosa and Brian A. Korgel
Read more: Highly Fluorescent Silicon Nanocrystals Stabilized in Water Using Quatsomes
NANOMOL Group has been accredited with the TECNIO certification as a Technology Developer Organization, until 2019.
Read more: NANOMOL Group accredited with the TECNIO certification
Li Yuan, Carlos Franco, Núria Crivillers, Marta Mas-Torrent, Liang Cao, C.S. Suchand Sangeeth, Concepció Rovira, Jaume Veciana, Christian A. Nijhuis
Read more: Chemical control over the energy-level alignment in a two-terminal junction
Sergi Galindo, Adrián Tamayo, Francesca Leonardi and Marta Mas-Torrent.
Adv. Funct. Mater. 2017, 1700526
During the last decades, small molecule organic semiconductors have been successfully used as active layer in organic field-effect transistors (OFETs).
Prof. Jaume Veciana has been named Scientific Director of the Singular Scientific Technological Infrastructures NANBIOSIS. This is one of the 29 ICTS which has been recently recognized by the Spanish Government (MINECO) comprising different units of the Biomedical Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Centre for Minimal Invasive Surgery Jesus Uson (CCMIJU). NANBIOSIS provides a wide range of services for the production and characterization of nanomaterials, biomaterials and biomedical devices.
NANOMOL launch the Nano4Derm project in collaboration with Almirall, and Leitat Technology Center, focused in nanomedicine applied to treat dermatological diseases. Within the framework of this research project, new innovative formulations containing nanoencapsulated active ingredients will be developed for the topical treatment of inflammatory skin conditions, such as Acne and Psoriasis.
On June 9th 2015, 16th Symposium on rare diseases was held at the Institute of Catalan Studies, in which the results of 20 research projects funded by TV3 Marathon Foundation in its edition of 2009 were presented.
